Ramsay Stattman Vela & Price’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.95M Sell
16,225
-1,335
-8% -$154K 0.39% 50
2025
Q4
$1.85M Sell
17,560
-621
-3% -$58.3K 0.33% 49
2025
Q3
$1.53M Sell
18,181
-4,428
-20% -$365K 0.27% 51
2025
Q2
$1.79M Sell
22,609
-830
-4% -$66K 0.33% 51
2025
Q1
$2.1M Sell
23,439
-6,626
-22% -$619K 0.4% 48
2024
Q4
$2.99M Buy
30,065
+85
+0.3% +$8.76K 0.56% 44
2024
Q3
$3.4M Sell
29,980
-2,655
-8% -$315K 0.63% 43
2024
Q2
$4.04M Sell
32,635
-1,760
-5% -$227K 0.76% 42
2024
Q1
$4.54M Sell
34,395
-1,010
-3% -$124K 0.87% 40
2023
Q4
$3.86M Sell
35,405
-870
-2% -$90.3K 0.79% 42
2023
Q3
$3.73M Sell
36,275
-5,680
-14% -$612K 0.81% 39
2023
Q2
$4.84M Sell
41,955
-1,145
-3% -$130K 0.99% 35
2023
Q1
$4.59M Sell
43,100
-5,055
-10% -$546K 0.99% 34
2022
Q4
$5.34M Buy
48,155
+3,775
+9% +$386K 1.2% 31
2022
Q3
$3.82M Sell
44,380
-3,640
-8% -$325K 0.95% 36
2022
Q2
$4.38M Buy
48,020
+20
+0% +$1.77K 0.98% 36
2022
Q1
$3.94M Sell
48,000
-410
-0.8% -$32.3K 0.77% 40
2021
Q4
$3.71M Buy
48,410
+1,010
+2% +$80.4K 0.84% 36
2021
Q3
$3.56M Buy
47,400
+2,565
+6% +$195K 0.89% 35
2021
Q2
$3.49M Sell
44,835
-2,561
-5% -$190K 0.86% 35
2021
Q1
$3.49M Buy
47,396
+4,072
+9% +$300K 0.92% 34
2020
Q4
$3.38M Buy
43,324
+3,448
+9% +$264K 0.95% 33
2020
Q3
$3.16M Buy
39,876
+2,085
+6% +$163K 0.98% 32
2020
Q2
$2.79M Buy
+37,791
New +$2.84M 0.96% 34

Other funds holding MRK

Ramsay Stattman Vela & Price's MRK Position: Q1 2026 in Review

Ramsay Stattman Vela & Price reduced its Merck (MRK) stake by 7.6% in Q1 2026, selling an estimated $154K and leaving 16,225 shares worth $1.95M. The position accounts for 0.39% of the portfolio, ranked #50.

Ramsay Stattman Vela & Price first reported a position in MRK in Q2 2020 and has held it in 24 quarters since. The position peaked at $5.34M in Q4 2022. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Ramsay Stattman Vela & Price held 16,225 shares of Merck worth $1.95M as of Q1 2026.
  • Ramsay Stattman Vela & Price sold 1,335 Merck shares in Q1 2026, an estimated $154K.
  • Merck made up 0.39% of Ramsay Stattman Vela & Price's portfolio in Q1 2026, its #50 holding.
  • Ramsay Stattman Vela & Price first reported a position in Merck in Q2 2020 and has held it in 24 quarters since.
  • Ramsay Stattman Vela & Price's Merck position peaked at $5.34M in Q4 2022.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ramsay Stattman Vela & Price's 13F filing for Q1 2026, filed 30 Apr 2026.